Drug Profile
Research programme: cyclin dependent kinase inhibitors - Merck
Alternative Names: CCT251545; MSC2530818Latest Information Update: 04 Sep 2023
Price :
$50
*
At a glance
- Originator Merck KGaA
- Class Small molecules
- Mechanism of Action Cyclin dependent kinase 19 inhibitors; Cyclin-dependent kinase 8 inhibitors; Wnt signalling pathway inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer